Functional mutation of SMAC/DIABLO, encoding a mitochondrial proapoptotic protein, causes human progressive hearing

Jing Cheng1, Yuhua Zhu, Sudan He

  • 1Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, China.

Insights

A SMAC/DIABLO gene mutation causes dominant progressive hearing loss (DFNA64). This mutation leads to mitochondrial dysfunction in inner ear hair cells, impacting hearing.

Area of Science:

  • Genetics
  • Cell Biology
  • Otolaryngology

Background:

  • SMAC/DIABLO is a mitochondrial protein crucial for apoptosis, counteracting inhibitor of apoptosis proteins (IAPs).
  • Progressive nonsyndromic hearing loss is a heterogeneous group of genetic disorders affecting auditory function.

Observation:

  • A novel heterozygous SMAC/DIABLO mutation (c.377C>T, p.Ser126Leu) was identified in a Chinese family with dominant progressive hearing loss (DFNA64).
  • SMAC/DIABLO shows high expression in embryonic ears and is concentrated in developing mouse inner ear hair cells.

Findings:

  • The identified SMAC/DIABLO(S71L) mutant retains proapoptotic function but induces degradation of both wild-type and mutant SMAC/DIABLO.
  • The mutant SMAC/DIABLO(S71L) compromises mitochondrial membrane potential, making them vulnerable to calcium-induced damage.

Implications:

  • This study identifies SMAC/DIABLO as a causative gene for DFNA64, a form of dominant progressive hearing loss.
  • Mutant SMAC/DIABLO(S71L) may lead to hearing impairment through mitochondrial dysfunction in inner ear hair cells.
  • This discovery opens new avenues for understanding the molecular mechanisms underlying genetic hearing loss.

Related Concept Videos

Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations01:39

Mutations

Overview
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...